What two key aspects must a DTx product demonstrate to secure reimbursement from payers?
Answer
Efficacy and economic value (cost-effectiveness).
Securing reimbursement requires demonstrating not just efficacy (does it work?) but also economic value, meaning it must be cost-effective compared to existing care.
Related Questions
How is digital therapeutics (DTx) primarily defined in terms of its function?What scientific rigor is characterized as necessary for the DTx space, distinguishing it from general digital health tools?What inherently characterizes the development process that contributes to high talent demand in DTx?Which specialized expertise is mentioned under the Technology & Engineering concentration for DTx roles?What specialized knowledge is crucial for the Commercial & Market Access concentration in DTx?What does the text cite as the unique expectation characterizing the DTx career landscape regarding skills?What benefit do tech professionals gain from partnerships with large biopharma companies?What two key aspects must a DTx product demonstrate to secure reimbursement from payers?What area is predicted to drive the next wave of high-value roles in DTx careers?What specific capability will drive hiring in health informatics and API development for future DTx platforms?